PROCEPT Q3 revenue $83.3M (+43% YoY); issues FY2026 guidance $410M-$430M

PROCEPT BioRobotics Corp

2025-Q3 EPS reported -$1.19 revenue$231,671,000

Q3 total revenue $83.3M, up 43% YoY; U.S. handpiece/consumables $44.4M (+50% YoY).
Net loss $21.4M vs $21.0M loss prior year; adjusted EBITDA loss $7.4M (vs $12.4M loss).
U.S. install base 653 systems, adding 58 systems in Q3.
FY2025 revenue guidance reaffirmed at ~$325.5M; FY2026 guidance range $410M-$430M.
Gross margin improved to 65% from 63% driven by operational efficiencies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.